In this position statement, developed by The International College of Obsessive-Compulsive
Spectrum Disorders, a group of international experts responds to recent developments in the …

Abstract Obsessive Compulsive Disorder (OCD) is a common mental disorder that often
causes great sufferance, with substantial impairment in social functioning and quality of life …

Serotonin reuptake inhibitor (SRI) medications are well established as first-line
pharmacotherapeutic treatment for Obsessive-Compulsive Disorder (OCD). However …

A wealth of data has been amassed that details a complex, yet accessible, series of
pathways by which the immune system, notably inflammation, can influence the brain and …

Abstract Introduction: Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) is a
clinically heterogeneous disorder with a number of different etiologies and disease …

Drug repositioning, also known as drug repurposing, reprofiling, or rediscovery, is
considered to be one of the most promising strategies to accelerate the development of new …

There appear to be two peaks of incidence of Obsessive Compulsive Disorder (OCD), one
with a pre-adolescent onset and another in early adulthood. As new cases are added, the …

What is known and objective N‐acetylcysteine (NAC) has been proposed as a potential
therapy for obsessive–compulsive disorder (OCD) as it may regulate the exchange of …

Neuropsychiatric disorders, such as depression, bipolar disorder, schizophrenia, obsessive-
compulsive disorder, and neurodevelopmental disorders such as autism spectrum disorder …

Background: Serotonin reuptake inhibitors (SRIs) and cognitive-behavioral psychotherapy
(CBT) are first-line treatments for obsessive-compulsive disorder (OCD). However, a …